PR View by Paul Oestreicher, PhD

Share this article:
CNN's sacking of some of its most experienced science journalists and producers could not come at a worse time. We are in desperate need of another science boom and greater public understanding and support will surely help propel the effort forward. Our healthcare, our environment, our energy needs and our economy all depend on it. 

Thirty years ago, the US ranked third among developed nations in the proportion of college students receiving degrees in science or engineering. Now, we stand in 17th place. Only about 10% of the US population knows what a molecule is and about half can define the purpose of DNA. So, we need more interest and investment, not less. We need more people informed, involved and inspired. 

Beyond the issue of competitiveness, there is consumer health and safety. Indeed, there is worry that a growing number of patients are not taking their medication because of inaccurate or sensationalized reporting on adverse drug reactions. Enhancing science literacy will create a more engaged, more rational health consuming public. To help accomplish this, we need to increase, not chop, the number of knowledgeable professionals sifting through the ballooning mass of information who can ask good questions, provide context and perspective, and differentiate the myths and the facts. 

Other news outlets are cutting back, too. I know the economy is tough. Even so, CNN, please reconsider.

Paul Oestreicher, PhD is president of Oestreicher Communications and adjunct professor at NYU
Share this article:
You must be a registered member of MMM to post a comment.

Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric